FWL Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FWL Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	95,070 +94,998	+131,942%	+$12.8M	2.76%	11
2026 Q1	$9.2K	Hold	72	–	–	﹤0.01%	258
2025 Q4	$8.78K	Hold	72	–	–	﹤0.01%	283
2025 Q3	$7.21K	Hold	72	–	–	﹤0.01%	275
2025 Q2	$5.97K	Sell	72 -23	-24%	-$1.83K	﹤0.01%	258
2025 Q1	$7.71K	Sell	95 -6,418	-99%	-$574K	﹤0.01%	237
2024 Q4	$587K	Sell	6,513 -114,005	-95%	-$11M	0.21%	58
2024 Q3	$11.9M	Buy	120,518 +15,014	+14%	+$1.48M	4.56%	4
2024 Q2	$9.78M	Buy	105,504 +54,644	+107%	+$4.9M	4.93%	5
2024 Q1	$4.83M	Buy	50,860 +50,856	+1,271,400%	+$4.72M	2.66%	16
2023 Q4	$357	Sell	4 -191	-98%	-$14.2K	﹤0.01%	222
2023 Q3	$14.2K	Buy	+195	New	+$15.6K	0.01%	138

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

FWL Investment Management's XBI Position: Q2 2026 in Review

FWL Investment Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 131,942% in Q2 2026, buying an estimated $12.8M and bringing the position to 95,070 shares worth $15M. The position accounts for 2.76% of the portfolio, ranked #11.

FWL Investment Management first reported a position in XBI in Q3 2023 and has held it in 12 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

FWL Investment Management held 95,070 shares of State Street SPDR S&P Biotech ETF worth $15M as of Q2 2026.
FWL Investment Management bought 94,998 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $12.8M.
State Street SPDR S&P Biotech ETF made up 2.76% of FWL Investment Management's portfolio in Q2 2026, its #11 holding.
FWL Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 12 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.